Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154 -

Primary Care Perspectives: Nirsevimab (Beyfortus) - Episode 154

Listen now

Description

For the first time, a preventative medicine is available to protect infants and high-risk toddlers from respiratory syncytial virus (RSV). Lori Handy, MD, MSCE, attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia, details the science behind the monoclonal antibody, nirsevimab (Beyfortus) and its importance, safety and efficacy, side effects, administration and proven benefits, such as a decrease in morbidity, as shown by clinical trials; and more.

More Episodes

See all »

Pre-exposure Prophylaxis (PrEP): HIV Prevention for Adolescents

As of 2020, 20% of new HIV diagnoses were among young people aged 13-24 years. Primary care pediatricians can play an important role in the prevention of HIV through standard, non-stigmatizing sexual health and HIV prevention care, which is why we are talking about PrEP with Sarah Wood, MD, MSHP,...

Published 05/06/24

Primary Care Perspectives: Episode 167-- Nutrition Advice for Premature Babies at Discharge from the NICU

The CHOP Neonatal Intensive Care Unit is working on enhancing communication of nutrition plans to primary care providers when infants are discharged. In this episode, Sarvin Ghavam, MD, an attending neonatologist and Kristina Spaide, MS, RD, CNSC, clinical nutrition manager, identify the unique...

Published 04/24/24

Primary Care Perspectives

Published 04/24/24